ELEM Biotech accelerated cardiac simulations by 40% using Viridien HPC , enabling faster insights and dramatically scaling virtual testing. Added speed and flexibility allows ELEM to test more therapies, generate critical evidence faster, and reduce risk—bringing virtual trials closer to reality and helping deliver safer, more effective treatments sooner.
CHALLENGE
Simulating the human heart at a cellular level remains highly compute-intensive, often requiring thousands of HPC cores. ELEM Biotech needed a faster, more scalable approach to improve efficiency, adapt on demand, and align performance with specific ROI goals. Key challenges included:
- Speed & efficiency – Balance performance with cost, as simulations can require 1,000+ cores
- Flexibility – A cloud solution that could scale on demand, as research and regulations evolve rapidly
- Customization – Fit-for-purpose HPC to accommodate specific short-term ROI metrics
RESULTS
By leveraging Viridien’s custom-built cloud infrastructure, ELEM Biotech could run simulations much faster than before, unlocking insights at record speed.
- Accelerated performance – Faster workloads enable more testing and quicker insights
- Scalable precision – Fine-tuned compute ensures compliance and accuracy
- Tailored value – Custom HPC cloud aligned to maximize ROI
40%Faster simulations | ScalableModel testing capacity | Max ROI+ Short-terms gains |
With Viridien HPC Cloud powering its research, ELEM Biotech is bringing the future of medicine closer – where treatments are tested virtually before they ever touch a patient.
Related products
Publications
Case StudyAuthors
Viridien